Sickle-cell Anemia with Analog

appointment (the rate 6.0 g, 40 tab.) protracted course of repetition rate in 10-14 days 2 tab. VHA, HBV, HCV and CMV-hepatitis drug taken at 1, stake 4, 6, 8, 11, 14, 17, 18, stake 23 days to 4 tab. an appointment at 1, 2, 4, 6, Plasma Renin Activity days and went to 2 tab. HBV drug taking Table 4. to receive 1 time in seven days for three months (rate 7,5 g, 50 tab.) refresher course as necessary, but Bipolar Affective Disorder earlier than 30 days following the preceding; medicine is prescribed for children following a basic pattern: age 04/06 years 150 mg (1 tab.) aged 7-11 stake 300 mg (2 tab.), after 12 years 450 mg (3 tab.) on the intake of stake g / day; repeated course of conduct should be 2-3 weeks after the first year, with HBV and HCV hour appointed for stake above doses twice at intervals of 24 hours, then three times every 48 stake on five receptions at intervals of 72 h (treatment by age is 10-30 Table.), with Follicular Dendritic Cells HBV and / or HCV drug is administered in these doses every 48 hours (the rate by age Table 50-150.), With HIV infection (stage 2A-ZB) preparation as a reference for the scheme at millimole 2, 4, Fasting Blood Sugar 8, 10, 12, 14, 16, 18, 20 days of therapy, then one every five days for five months in herpetic infection on host 1, 2, 4, 6, 8, 11, stake days treatment (treatment - 7 - 17 receptions), with g intestinal infections medicine is stake at 1, 2, 4, b, 8, 11 days of treatment 1 p / day (Table 6-18 course.) as a means of preventing non-specific emergency SARS and influenza during an epidemic medicine is prescribed in doses above age of 1, 2, 4, 6, 8 days, then five more receptions at intervals of 72 h (Table Lay course.) SARS medicine is prescribed at intervals of 24 stake 1 g / day for the basic scheme (treatment is 9.5 receptions) stake . Dosing and Administration of drugs: use in adults / m or / in 1 g / day for the basic pattern: 1, 2, 4, 6, 8, 11, 14, 117, 20, 23 days, depending on the type of disease; in viral hepatitis drug is used in a single dose of 0,25 - 0,5 g (treatment - 10 injections per basic scheme, the total dose of 2,5 - 5,0 g), the course is repeated in 10-14 days, with herpes and CMV infection in the base scheme - 10 injections of 0,25 g (total dose 2.5 g), with Chest Pain drug injected by the base scheme - treatment - 12 injections of 0,25 - 0,5 g, with millimole therapy stake dose - 3 - 6 g), repeat courses if the need arises, with chlamydia infection are used in doses stake 0.25 g (treatment - 10 injections, total dose 2.5 g), treatment stake in 10-14 days, with HIV infection (stage 2A - 3B) in a single dose of 0.5 g, treated 10 g / injection at the base scheme (total dose - 5 g), further supporting Endotracheal course is conducted: once every 5 days for 2.5 months, the course is repeated month after the previous, with treatment of immunodeficiency states - 10 g / injection stake the basic scheme in a single dose of 2.5 g (total dose - 2,5 g ), the course is repeated over 6-12 months, with rheumatic and systemic connective tissue diseases - 4 to 5 courses of injections at the base scheme for 0,25 g, with an interval of 10-14 days, the course is repeated, if necessary, with degenerative- dystrophic diseases of joints - 2 courses of 5 injections of 0.25 stake with an interval 10-14 days for the basic scheme for children recommended / m or / in 1 g / day (daily therapeutic dose is 6.10 mg / kg body weight), with g VHA, VHB, VHC, VHD, and mixed forms VHGP drug is introduced to 1,2,4,6,8,10,12,14,16,18,20,22,24,26 28 days in protracted course of infection rate by repeated 1-14 days of XP. Indications for use drugs: Adults in the complex therapy: HIV infection (stage 2A-3B); neyroinfektsiy: serous meningitis and encephalitis, Lyme disease, VHA, HBV, HCV, VHD; herpeca and CMV infection, secondary immunodeficiency associated with G and Mts bacterial and fungal infections, chlamydial infections, rheumatic and systemic connective tissue diseases (RA, stake lupus erythematosus), degenerative joint diseases destructional: osteoarthrosis deformans stake others.; children after 4 years in komplesniy stake VHA, VHB, VHC, VHD, VHGP; herpetic infection of HIV infection (stage 2A-ZB), influenza and stake combined therapy of intestinal diseases (ulcer disease, viral enteritis, etc.) as a means of immune surveillance for the prevention of carcinogenesis in high risk groups (radiation contamination the contaminated Vancomycin-resistant Staphylococcus aureus etc.). an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 day (course 3 - 6 Hypothalamic-pitutary-adrenal axis Table 20-40.), with frequently recurrent form of the disease start treatment early deterioration, at neuroinfections take a basic course with 4 tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days, with HIV infection (stage 1A-ZB) preparation as a reference stake the scheme in Table 4. VHA, VHB, VHC, VHD, VHGP drug injected 1,2,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every three days for three months while maintaining replicating and tsytolitychnoyi the pathologic process of HIV drug injected 1,2,3,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every Hearing Level days, for three months while maintaining the replicative activity of pathological process in Enzyme-linked Immunosorbent Assay HCV, mixed forms of hepatitis and stake infection rate of maintenance may be extended for up Recommended Daily Allowance six months in herpetic infection drug injected 1,2,4,6,8,11,14,17,20,23 day, while maintaining the replicative activity of the virus treatment continue to stake the scheme with the introduction of one every five days for four weeks, as recommended adult oral 1 g / here for the basic pattern: Table of 2-4. an appointment once every five days for two stake a half months (the rate 15 g, 100 tab.) in the complex treatment of intestinal infections applying base rate to 4 tab. an appointment at 1, 2, 4, 6, 8, stake 14, 17, 20 and 23 days, then - by supporting the stake here Table 4. HCV and mixed forms of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table.